Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.48%
#2 Ocean Protocol Ocean Protocol +22.42%
#3 Geodnet Geodnet +14.73%
#4 Audiera Audiera +11.80%
#5 KUB Coin KUB Coin +8.63%
#6 Arowana Arowana +7.85%
#7 DexNet DexNet +7.78%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.66%
#9 Rollbit Coin Rollbit Coin +6.27%
#10 Cysic Cysic +6.18%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Rank in Stocks #32244
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Share Price
$4.65
Last synced: 2024-07-24
Market Cap
$10.63M
Change (1 day)
6.66%
Change (1 year)
0.00%
Country
AU
Trade Medlab Clinical Limited (MDC)

Category

Healthcare
Revenue for Medlab Clinical Limited (MDC)
Revenue in Aug 2026 TTM: 0
According to Medlab Clinical Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Medlab Clinical Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR